Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
<p><strong>Background</p></strong> Cardiovascular disease incidence and mortality have declined across developed economies and granular up-to-date cost-effectiveness evidence is required for treatments targeting large populations. To assess the health benefits and cost-effect...
Main Authors: | Mihaylova, B, Wu, R, Zhou, J, Williams, C, Schlackow, I, Emberson, J, Reith, C, Keech, A, Robson, J, Parnell, R, Armitage, J, Gray, A, Simes, J, Baigent, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2024
|
Títulos similares
-
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyResearch in context
por: Borislava Mihaylova, et al.
Publicado: (2024-05-01) -
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
por: Wu, R, et al.
Publicado: (2023) -
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
por: Mihaylova, B, et al.
Publicado: (2024) -
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant datasets
por: Mihaylova, B, et al.
Publicado: (2024) -
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets
por: Borislava Mihaylova, et al.
Publicado: (2024-12-01)